²é¿´: 866  |  »Ø¸´: 5
±¾Ìû²úÉú 1 ¸ö LS-EPI £¬µã»÷ÕâÀï½øÐв鿴

dengxianqing

ľ³æ (СÓÐÃûÆø)

[ÇóÖú] °ïæ²éһƪ Eur J Med ChemÂÛÎĵļìË÷ºÅºÍËûÒýÇé¿ö

ÂÛÎÄÏêϸÐÅÏ¢ÈçÏ£ºMing-Xia Song, Chang-Ji Zheng, Liang-Peng Sun, Yan Wu, Lan Hong, Ying-Jing Li, Yi Liu, Zhi-Yu Wei, Ming-Jun Jin, Hu-Ri Piao*. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA). Eur J Med Chem. 60, 376-385, 2013.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
dengxianqing: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2014-09-20 09:40:26
oven1986: LS-EPI+1, ¸ÐлӦÖú£¡ 2014-09-21 00:38:11

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

2Â¥2014-09-19 21:39:23
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
dengxianqing: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2014-09-20 09:41:10
Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA)


×÷Õß:Song, MX (Song, Ming-Xia)[ 1,2 ] ; Zheng, CJ (Zheng, Chang-Ji)[ 1 ] ; Deng, XQ (Deng, Xian-Qing)[ 1 ] ; Sun, LP (Sun, Liang-Peng)[ 1 ] ; Wu, Y (Wu, Yan)[ 1 ] ; Hong, L (Hong, Lan)[ 3 ] ; Li, YJ (Li, Ying-Jing)[ 1 ] ; Liu, Y (Liu, Yi)[ 1 ] ; Wei, ZY (Wei, Zhi-Yu)[ 1 ] ; Jin, MJ (Jin, Ming-Jun)[ 1 ] ¸ü¶àÄÚÈÝ




EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY



¾í: 60

Ò³: 376-385

DOI: 10.1016/j.ejmech.2012.12.007

³ö°æÄê: FEB 2013

²é¿´ÆÚ¿¯ÐÅÏ¢





























ÕªÒª

With an intention to synergize the anti-bacterial activity of 5-aryloxy pyrazole and rhodanine derivatives, eight series of hybrid compounds have been synthesized and evaluated for their antibacterial activity. The majority of the synthesized compounds showed good inhibitory activity against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA, QRSA) with minimum inhibitory concentration (MIC) values in the range of 1-32 mu g/mL. The cytotoxicity test suggests that these compounds exhibited in vitro antibacterial activity at non-cytotoxic concentrations. These studies therefore suggest that rhodanine-based 5-aryloxy pyrazoles are interesting scaffolds for the development of novel Gram-positive antibacterial agents. (C) 2012 Elsevier Masson SAS. All rights reserved.


¹Ø¼ü´Ê

×÷Õ߹ؼü´Ê:Rhodanine; 5-Aryloxy pyrazole; Anti-bacterial; MRSA; QRSA

KeyWords PlusERIVATIVES; 4-THIAZOLIDINONE; AGENTS


×÷ÕßÐÅÏ¢

ͨѶ×÷ÕßµØÖ·: Piao, HR (ͨѶ×÷Õß)





Yanbian Univ, Coll Pharm, Affiliated Minist Educ, Key Lab Nat Resources & Funct Mol Changbai Mt, 977 Gongyuan Rd, Yanji 133002, Jilin, Peoples R China.





µØÖ·:





[ 1 ] Yanbian Univ, Coll Pharm, Affiliated Minist Educ, Key Lab Nat Resources & Funct Mol Changbai Mt, Yanji 133002, Jilin, Peoples R China





      

[ 2 ] Jinggangshan Univ, Coll Med, Jian 343100, Jiangxi, Peoples R China





[ 3 ] Yanbian Univ, Coll Med, Yanji 133002, Jilin, Peoples R China





µç×ÓÓʼþµØÖ·:piaohuri@yahoo.com.cn


»ù½ð×ÊÖúÖÂл



»ù½ð×ÊÖú»ú¹¹

ÊÚȨºÅ



National Science Foundation of China


20962021

81260468

²é¿´»ù½ð×ÊÖúÐÅÏ¢   




³ö°æÉÌ

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, 75724 PARIS, FRANCE


Àà±ð / ·ÖÀà

Ñо¿·½Ïòharmacology & Pharmacy

Web of Science Àà±ð:Chemistry, Medicinal


ÎÄÏ×ÐÅÏ¢

ÎÄÏ×ÀàÐÍ:Article

ÓïÖÖ:English

Èë²ØºÅ: WOS:000316242700038

ISSN: 0223-5234


ÆÚ¿¯ÐÅÏ¢


Impact Factor (Ó°ÏìÒò×Ó): Journal Citation Reports®


ÆäËûÐÅÏ¢

IDS ºÅ: 107TC

Web of Science ºËÐĺϼ¯ÖÐµÄ "ÒýÓõIJο¼ÎÄÏ×": 13

Web of Science ºËÐĺϼ¯ÖÐµÄ "±»ÒýƵ´Î": 3









»¯ºÏÎï 1 ÖÁ 10
















1.

»¯ºÏÎïÏêϸÐÅÏ¢










2.

»¯ºÏÎïÏêϸÐÅÏ¢












3.

»¯ºÏÎïÏêϸÐÅÏ¢










4.

»¯ºÏÎïÏêϸÐÅÏ¢












5.

»¯ºÏÎïÏêϸÐÅÏ¢










6.

»¯ºÏÎïÏêϸÐÅÏ¢












7.

»¯ºÏÎïÏêϸÐÅÏ¢










8.

»¯ºÏÎïÏêϸÐÅÏ¢












9.

»¯ºÏÎïÏêϸÐÅÏ¢










10.

»¯ºÏÎïÏêϸÐÅÏ¢






ÒýÎÄÍøÂç




3 ±»ÒýƵ´Î

13 ÒýÓõIJο¼ÎÄÏ×

²é¿´ Related Records

²é¿´ÒýÖ¤¹ØÏµÍ¼

´´½¨ÒýÎĸú×Ù

(Êý¾ÝÀ´×Ô Web of ScienceTM ºËÐĺϼ¯)



È«²¿±»ÒýƵ´Î¼ÆÊý



3 / ËùÓÐÊý¾Ý¿â

3 / Web of Science ºËÐĺϼ¯

3 / BIOSIS Citation Index

0 / Öйú¿ÆÑ§ÒýÎÄÊý¾Ý¿â

0 / Data Citation Index

0 / SciELO Citation Index


×î½üµÄÒýÎÄ









Ma, Long-Xu. Synthesis and positive inotropic evaluation of [1,2,4]triazolo [3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted piperazine moieties. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, APR 1 2014.



²é¿´È«²¿



´Ë¼Ç¼À´×Ô:

Web of ScienceTM ºËÐĺϼ¯


½¨ÒéÐÞÕý


Èç¹ûÏ£ÍûÌá¸ß´Ë¼Ç¼ÖÐÊý¾ÝµÄÖÊÁ¿£¬ÇëÌṩÐÞÕý½¨Òé¡£
3Â¥2014-09-19 21:39:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
dengxianqing: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2014-09-20 09:41:19
Èë²ØºÅ: WOS:000316242700038
4Â¥2014-09-19 21:39:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

dengxianqing

ľ³æ (СÓÐÃûÆø)

Ëͺ컨һ¶ä
ÒýÓûØÌû:
2Â¥: Originally posted by baiyuefei at 2014-09-19 21:39:23
https://apps.webofknowledge.com/full_record.do?product=WOS&search_mode=GeneralSearch&qid=3&SID=N1beq2jlZdqpnQECzW3&page=1&doc=1&UT=WOS:000316242700038

ÄÜÂé·³Äã°ïÎÒÖØ·¢Ò»´Î¸ÃÁ´½ÓÂð£¿ÕæÊǷdz£×ż±£¬Âé·³À²
5Â¥2014-09-20 13:24:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

baiyuefei

°æÖ÷ (ÎÄѧ̩¶·)

·çÑ©

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÎÄÏ׽ܳö¹±Ï×ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

ÒýÓûØÌû:
5Â¥: Originally posted by dengxianqing at 2014-09-20 13:24:10
ÄÜÂé·³Äã°ïÎÒÖØ·¢Ò»´Î¸ÃÁ´½ÓÂð£¿ÕæÊǷdz£×ż±£¬Âé·³À²...

https://apps.webofknowledge.com/ ... p;preferencesSaved=
6Â¥2014-09-20 14:41:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ dengxianqing µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á +11 ÊÖ»úÓû§ 2026-03-17 12/600 2026-03-23 23:51 by ÈÈÇéɳĮ
[¿¼ÑÐ] ²ÄÁÏ/ũҵרҵ£¬07/08¿ªÍ·¾ù¿É£¬¹ýÏß¾ÍÐÐ +3 ºÇßíŶ»í 2026-03-23 4/200 2026-03-23 22:30 by Íô£¡£¿£¡
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖÐÄÏ´óѧ»¯Ñ§Ñ§Ë¶0703×Ü·Ö337Çóµ÷¼Á +5 niko- 2026-03-22 5/250 2026-03-23 22:01 by fuyu_
[¿¼ÑÐ] Ò»Ö¾Ô¸211 ³õÊÔ270·Ö Çóµ÷¼Á +4 ¹ÈÓêÉϰ¶ 2026-03-23 5/250 2026-03-23 21:18 by ²»»ó¿ÉÀÖ
[¿¼ÑÐ] ²ÄÁÏר˶ӢһÊý¶þ306 +8 z1z2z3879 2026-03-18 8/400 2026-03-23 20:49 by baobaoye
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +4 ÄÌÓͲÝÝ®. 2026-03-22 5/250 2026-03-23 19:37 by pswait
[¿¼ÑÐ] Çóµ÷¼Á²ÄÁÏѧ˶080500£¬×Ü·Ö289·Ö 5+3 @taotao 2026-03-19 21/1050 2026-03-23 10:17 by ¹Úc¸ç
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +5 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 5/250 2026-03-22 16:42 by tcx007
[¿¼ÑÐ] 303Çóµ÷¼Á +5 °²ÒäÁé 2026-03-22 6/300 2026-03-22 12:46 by ËØÑÕÇã³Ç1988
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤306 +4 z1z2z3879 2026-03-21 4/200 2026-03-21 23:44 by ms629
[¿¼ÑÐ] 286Çóµ÷¼Á +10 Faune 2026-03-21 10/500 2026-03-21 23:34 by 314126402
[¿¼ÑÐ] 22 350 ±¾¿Æ985Çóµ÷¼Á£¬ÇóÀϵÇÊÕÁô +3 ÀîéóÄÐ003 2026-03-20 3/150 2026-03-21 13:28 by ²«»÷518
[¿¼ÑÐ] 304Çóµ÷¼Á +6 ÂüÊâ2266 2026-03-18 6/300 2026-03-21 00:32 by JourneyLucky
[¿¼ÑÐ] 295Çóµ÷¼Á +4 Ò»Ö¾Ô¸¾©Çø211 2026-03-18 6/300 2026-03-20 23:41 by JourneyLucky
[¿¼ÑÐ] 290Çóµ÷¼Á +7 ^O^Ø¿ 2026-03-19 7/350 2026-03-20 21:43 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»Í¨ ר˶ ²ÄÁÏ355 ±¾¿ÆË«·Ç Çóµ÷¼Á +5 Î÷ÄϽ»Í¨×¨²Ä355 2026-03-19 5/250 2026-03-20 21:10 by JourneyLucky
[¿¼ÑÐ] 288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005 +5 ioodiiij 2026-03-17 5/250 2026-03-19 18:22 by zcl123
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +5 pupcoco 2026-03-17 8/400 2026-03-19 13:58 by houyaoxu
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +3 ÄÝÄÝninicgb 2026-03-17 3/150 2026-03-18 10:29 by macy2011
[¿¼ÑÐ] ²ÄÁÏ£¬·ÄÖ¯£¬ÉúÎ0856¡¢0710£©£¬»¯Ñ§ÕÐÉúÀ² +3 Eember. 2026-03-17 9/450 2026-03-18 10:28 by Eember.
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û